AtaiBeckley Inc.|4Feb 3, 6:54 PM ET

Craig Kevin James 4

4 · AtaiBeckley Inc. · Filed Feb 3, 2026

AI-generated summary of this filing

Updated Feb 3, 2026

AtaiBeckley (ATAI) CMO Craig James Receives Equity Awards

What Happened

Craig Kevin James, Chief Medical Officer of AtaiBeckley Inc. (ATAI), received equity awards on January 30, 2026: 675,000 stock options and 150,000 restricted stock units (RSUs). Both grants are reported as derivative acquisitions at $0.00 per share (transaction code A).
These awards involve no cash paid at grant. The filing does not state a fair-market dollar value for the grants.

Key Details

Transaction date: 2026-01-30; Form 4 filed: 2026-02-03 (timely).
Grants: 675,000 options (derivative) and 150,000 RSUs (derivative); price reported $0.00.
Shares owned after transaction: not disclosed in the provided filing summary.
Vesting (from footnotes):
- Options (F1): 25% vest on January 1, 2027, then the remaining 75% vests in 36 substantially equal monthly installments thereafter.
- RSUs (F2): 25% vest on January 1, 2027, then the remaining 75% vests in three equal annual installments on the first three anniversaries of January 1, 2027.
Exhibit noted: Exhibit 24 (Power of Attorney).

Context

These grants are compensation awards (code A). Options give the holder the right to buy shares in the future; RSUs convert to shares when they vest. Neither represents an immediate market purchase or sale.
Such awards are common for executives and reflect long-term compensation tied to continued service and/or performance; they should not be interpreted on their own as a buy or sell signal.

Form 4

Period: 2026-01-30

Chief Medical Officer

Transactions

Award
Stock Option
[F1]
2026-01-30+675,000→ 675,000 total
Exercise: $3.76Exp: 2036-01-30→ Common Stock (675,000 underlying)
Award
Restricted Stock Units
[F2]
2026-01-30+150,000→ 150,000 total
→ Common Stock (150,000 underlying)

Footnotes (2)

[F1]The stock option vests (subject to continued service through each such vesting date) as to 25% of the total number of shares underlying the option on January 1, 2027 and as to the remaining 75% of the total number of shares in 36 substantially equal monthly installments thereafter.
[F2]Each restricted stock unit vests (subject to continued service through each such vesting date) as to 25% of the total number of shares underlying such award on January 1, 2027 and as to the remaining 75% of the total number of shares on each of the first three anniversaries of January 1, 2027.

Signature

/s/ Ryan Barrett, as attorney in fact|2026-02-03

2 files